BECOME A MEMBER
Connect with healthcare professionals around the globe to get the most up-to-date medical cannabis information.
Get Involved
TAKE OUR COURSES
The curriculum brings hands-on practical guidance on how to develop personalized treatment regimens and more.
The antimicrobial potential of cannabidiol
Authors Mark A. T. Blaskovich, Angela M. Kavanagh, Alysha G. Elliott, Bing Zhang, Soumya Ramu, Maite Amado, Gabrielle J. Lowe, Alexandra O. Hinton, Do Minh Thu Pham, Johannes Zuegg, Neil…
NICM Cannabis for Endometriosis Survey
Do you have endometriosis and use cannabis (legally prescribed or illicit) to manage your
symptoms? Researchers from Western Sydney University and the University of New South Wales are interested in finding out more about the potential use of cannabis to manage endometriosis pain.
Therapeutic potential of cannabinoids in combination cancer therapy
SCC member Kenzi Riboulet-Zemouli identifies a coherent nomenclature for cannabis products (whether derived from Cannabis sativa L. or not). The paper was published in Drug Science, Policy and Law in December of 2020.
Use of Cannabis for Self-Management of Chronic Pelvic Pain
SCC member Kenzi Riboulet-Zemouli identifies a coherent nomenclature for cannabis products (whether derived from Cannabis sativa L. or not). The paper was published in Drug Science, Policy and Law in December of 2020.
Cannabis Medicine in Neurology
Dr. Ethan Russo, Dr. Paola Pineda, and Dr. Max Alzamora present their findings on the potential applications of cannabinoid therapy in the field of neurology.
Cannabis in Medicine: Pain [VIDEO]
SCC Board Members discuss how cannabis can help treat and manage chronic and acute pain. Genester Wilson-King, MD, Stephen Robinson, MD, and Sherry Yafai, MD explore existing research, case reports, and identify the potential future role cannabis could play in healthcare.
‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology
SCC member Kenzi Riboulet-Zemouli identifies a coherent nomenclature for cannabis products (whether derived from Cannabis sativa L. or not). The paper was published in Drug Science, Policy and Law in December of 2020.
Cannabis Significantly Reduces the Use of Prescription Opioids and Improves Quality of Life in Authorized Patients: Results of a Large Prospective Study
Authors Philippe Lucas, MA PhD, Susan Boyd, PhD, M -J Milloy, PhD, Zach Walsh, PhD Published in Pain Medicine December 2020 Abstract Objective This article presents findings from a large…
Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees
Authors Hefei Wen, PhD; Jason M. Hockenberry, PhD Published in JAMA Internal Medicine May 2018 Abstract Importance Overprescribing of opioids is considered a major driving force behind the opioid epidemic in…
Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Authors Carolina Chaves, MD, Paulo Cesar T Bittencourt, MD, MSc, Andreia Pelegrini, PhD Published in Pain Medicine October 2020 Abstract Objective To determine the benefit of a tetrahydrocannabinol (THC)-rich cannabis…
Soul Lounge Primetime: Cannabis & Social Equity [VIDEO]
The adult use of cannabis has been legalized in various states in the USA. But issues surrounding social justice, social equity, and inclusion in the cannabis industry remain unclear.
Safety Considerations in Cannabinoid-Based Medicine
Authors Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Anton Uribayev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Mahmud Abo-Amna, Luiza Akria, Dmitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Or Hazan,…